Delivery Order SPE2DB24D1205-SPE2DB24FCRLL
Award Date 5/21/24
Potential Completion Date 5/22/24
Potential Value $7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency of the U.S. Department of Defense. The contract is a firm fixed price delivery order awarded to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract has a ceiling value of $4,317.40 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA). The $1,295.22 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies. The contract has an ultimate completion date of October 25, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The $3,341.25 firm fixed-price delivery order contract has a period of performance through July 10, 2025 and was awarded on July 9, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is not set aside and is part of Amerisourcebergen's larger $999,999,999.00 Indefinite...
- This federal contract award is for the supply of IMOVAX rabies vaccine vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract, valued at $2,158.70, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, on June 28, 2024. The contract is a delivery order with a firm fixed price and a completion date of July 1, 2024. Amerisourcebergen, through its Corporate Office Division, is the prime contractor and there is no...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $2,822.89 and is a Firm Fixed Price Delivery Order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the procurement of IMOVAX RABIES VACCINE VIALS by the Defense Logistics Agency (DLA) from Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,421.14 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of December 10, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This federal contract award is for the delivery of IMOVAX RABIES VACCINE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is a Delivery Order with a Firm Fixed Price of $7,360.76 and has an ultimate completion date of May 23, 2025. This award is not associated with a set-aside program. Amerisourcebergen...
- This federal contract award, valued at $14,728.79, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of IMOVAX RABIES VACCINE VIALS. The contract, which has a period of performance through November 7, 2024, is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of IMOVAX Rabies vaccine vials to the Defense Logistics Agency (DLA). The contract, valued at $1,339.98, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a firm fixed-price pricing type and an ultimate completion date of December 10, 2024. The contract is a delivery order and is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IMOVAX RABIES VACCINE VIALS, with a ceiling value of $2,673.00 and a period of performance through July 2, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...